China, Nov. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'CLDN18.2 expression-guided selection of neoadjuvant/conversion chemotherapy regimens for pancreatic cancer: A prospective, multicenter, randomized controlled trial'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136701

Registration Time: 2026/11/14

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital of Naval Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=348966

Published by HT Digital Content Services with permission from Health Daily Digest....